These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10199144)

  • 1. [Syndrome X].
    Kotake H; Oikawa S
    Nihon Rinsho; 1999 Mar; 57(3):622-6. PubMed ID: 10199144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of the insulin resistance syndrome (syndrome X).
    Chisholm DJ; Campbell LV; Kraegen EW
    Clin Exp Pharmacol Physiol; 1997; 24(9-10):782-4. PubMed ID: 9315389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible insulin resistance in non-insulin-dependent diabetes mellitus.
    Karam JH
    Horm Metab Res; 1996 Sep; 28(9):440-4. PubMed ID: 8911980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
    Schernthaner GH; Schernthaner G
    Scand J Clin Lab Invest Suppl; 2005; 240():30-40. PubMed ID: 16112958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipotoxicity and the insulin resistance syndrome.
    Anderwald C; Roden M
    Pediatr Endocrinol Rev; 2004 Mar; 1(3):310-9. PubMed ID: 16437024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic criteria of insulin resistance and multiple risk factor syndrome].
    Hashimoto N; Saito Y
    Nihon Rinsho; 2000 Feb; 58(2):405-10. PubMed ID: 10707566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in obesity as the underlying cause for the metabolic syndrome.
    Gallagher EJ; Leroith D; Karnieli E
    Mt Sinai J Med; 2010; 77(5):511-23. PubMed ID: 20960553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Obesity and insulin resistance syndrome].
    Tokunaga K; Matsuzawa Y
    Nihon Rinsho; 1996 Oct; 54(10):2679-86. PubMed ID: 8914427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of insulin resistance and associated diseases.
    Mlinar B; Marc J; Janez A; Pfeifer M
    Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose tissue distribution, plasma insulin, and cardiovascular disease.
    Björntorp P
    Diabete Metab; 1987 Jul; 13(3 Pt 2):381-5. PubMed ID: 3308569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-pharmacological therapy of metabolic syndrome].
    Wirth A
    Herz; 1995 Feb; 20(1):56-69. PubMed ID: 7713478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Macronutrients, fat mass, fatty acid flux and insulin sensitivity].
    Ziegler O; Quilliot D; Guerci B; Drouin P
    Diabetes Metab; 2001 Apr; 27(2 Pt 2):261-70. PubMed ID: 11452220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance.
    Blaak EE
    Best Pract Res Clin Endocrinol Metab; 2005 Sep; 19(3):391-403. PubMed ID: 16150382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PASSCLAIM--body weight regulation, insulin sensitivity and diabetes risk.
    Riccardi G; Aggett P; Brighenti F; Delzenne N; Frayn K; Nieuwenhuizen A; Pannemans D; Theis S; Tuijtelaars S; Vessby B
    Eur J Nutr; 2004 Jun; 43 Suppl 2():II7-II46. PubMed ID: 15221353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.